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ABSTRACT 
Objective:  This study aimed to assess the incidence of anxiety and depression among AMI patients during 
COVID-19 pandemic in Pakistan. 
Material & Method:  This cross-sectional study was conducted from February 27 to June 2, 2020, at the 
Cardiology ward of Dera Ghazi Khan Teaching Hospital.  Total 611 patients selected through convenience 
sampling. The patients were requested to respond to Hospital Anxiety and Depression Scale (HADS) and 
demographic information. An independent samples t test was applied for comparisons. 
Results:  Patients’ age was ranging from 41 to 79 years, with a mean age of 52.35 ± 5.12. There was a high 
frequency of anxiety (51.72%) and depression (34.86%) among AMI patients. A significant difference was 
observed in the level of anxiety (p = 0.001) and depression (p = 0.000) among male and female patients. 
Conclusion:  The present study findings affirmed that increased level of anxiety and depression are 
prevalent in AMI patients. Additionally, both anxiety and depressive symptoms were more common in 
female patients. 
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INTRODUCTION 
COVID-19 is declared as a global health crisis with 
high death rates and infected individuals. Cardiac 
patients are particularly at high risk of dying from 
COVID-19 due to their ill health and vulnerability 
for a myocardial involvement.1 Acute myocardial 
infarction (AMI) is a cardiac emergency and needs 
immediate diagnosis and treatment. Therefore, 
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COVID-19 the highly infectious pneumonia affects 
the diagnosis and treatment of AMI. According to 
World health organization,2 depression is the 
second leading reason of disability worldwide by 
2020. Depression is an important root cause of 
mental illness and death, especially in patients 
with heart disease. Depression and anxiety are 
thought of as one of the main reasons of 
morbidity and death in patients with heart 
disease, such as myocardial infarction (MI).3,4,5 
Thus, MI is a serious, life-threatening event which 
can increase the risk for depression and anxiety.6,7 
 After the occurrence of any acute cardiac 
event such as AMI, both anxiety and depression 
are common to happen. In general, it is 
acceptable for one in five patients diagnosed with 
depression and one in three to suffer from severe 
anxiety symptoms during hospitalization for heart 
disease.8,9,10 Patients who suffer from anxiety or 
depression after experiencing an acute cardiac 
event are at greater risk of going through later 
events and even untimely death.11 Adverse health 
effects appear or are exacerbated when signs of 
anxiety or depression persist or occur after 
discharge from the hospital or during recovery 
from cardiac event.12,13,14 It has been found 
through a 12 – years follow-up study that 170 
women with AMI and coronary artery bypass graft 
surgery (CABG) have the highest mortality rate 
whose depressive symptoms are worsened and 
lowest among those women whose symptoms 
have improved in the two months after discharge 
from the hospital.12 Even anxiety symptoms 
remaining for one to two months after post-event 
increases the risk for an adverse cardiac event.15 
Therefore, screening patients who are at risk of 
developing signs and symptoms of anxiety or 
depression is very important, not only those 
whose symptoms are present during 
hospitalization but also develop after recovering 
from any cardiac event.10 
 In recent years, the mechanisms of the 
association between coronary heart disease (CHD) 
and mental health are well recorded in various 
published reviews. It is proposed that CHD, 
anxiety, and depression have many common 
biological mechanisms. For example, individual 
having depressive symptoms can also have a high 
level of biological makers that increase 
atherosclerosis. Both anxiety and depression 
decreased parasympathetic activities are 
suggestive of decrease in the variability heart 
rate, alteration in serotonergic pathways as well 
as in platelet aggregability, and increased level of 
C-reactive protein, which is a sign of high 
inflammatory response. Another mechanism 
involves impairment of the cardiac neuronal 
reuptake of noradrenaline in the heart in patients 
with anxiety and depressive symptoms.16 
 Thus, the present study is carried out to 
assess the incidence of anxiety and depression 
among Acute Myocardial Infarction patients 
during the COVID-19 pandemic. Although studies 
have been conducted in Pakistan to assess 
anxiety and depression in Acute Myocardial 
Infarction patients, but this research study 
contributes to the existing literature through 
studying anxiety and depression in times 
ofCOVID-19. 
 
MATERIAL & METHODS 
Study Setting and Design 
A cross-sectional study was completed with 611 
Acute Myocardial Infarction patients (male = 367, 
female = 244) after obtaining consent from them. 
The patients were included from the Cardiology 
Ward of Dera Ghazi Khan Teaching Hospital from 
February 27 to June 2, 2020. The convenience 
sampling technique was used. 
 
Data Collection 
Only those patients were included, who were 
survived from Acute Myocardial Infarction (AMI). 
Non-survivors were excluded from the study. The 
approached patients were then requested to fill 
out the questionnaires. They were also asked to 
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provide demographic information about their 
gender, age, education, marital status, family 
system, and occupation. 
 
Instrument 
The Hospital Anxiety and Depression Scale 
(HADS),17 is one of the widely applied instruments 
to assess anxiety and depressive symptoms. The 
present study used HADS Urdu translated version 
developed by Mumford et al, for the convenience 
of patients. HADS comprised of 14 items, seven 
items for each subscale. The participants gave 
their responses about their experience over the 
past week. The maximum score was, therefore, 21 
for depression and anxiety. As HADS was a very 
brief instrument, so it took only 5 to 10 minutes 
to complete it. HADS scores for each subscale 
were categorized into three; these are: (i) Normal 
ranged from 1 to 7, (ii) borderline ranged from 8 
to 10, and (iii) abnormal ranged from 11 to 21. 
Cronbach’s alpha for HADS-A varied from .68 to 
.93 and for HADS-D from .67 to .90. 
 
Statistical Calculation 
All the participants were selected through 
convenience sampling and asked to provide their 
responses on a booklet containing study 
instrument and demographic information sheet. 
They were ensured about the confidentiality of 
their responses to the questionnaires. Descriptive 
statistics and independent sample t- test were 




Patients’ age was ranging from 41 to 79 years, 
with a mean age of 52.35 ± 5.12. Table 1 shows a 
sample of 611 (male = 60.07%, female = 39.93%) 
patients with Acute Myocardial Infarction. 
Patients’ age range was categorized into four 
groups, i.e. 40 to 49 (4.73%), 50 to 59 (28.31%), 60 
to 69 (34.21%) and 70 to 79 (22.75%). Educational 
level was also categorized into four types; these 
were matriculation, intermediate, bachelors, and 
masters; therefore, most of the patients had 
completed their matriculation i.e., 52.86%. Hence, 
85.76% of the patients reported that they were 
married and living in a joint family system 
(77.09%) and doing some kind of job (71.19%). 
Scores on the HADS anxiety scale showed that 
most patients lie in the abnormal range (51.72%) 
whereas, HADS depression scale score depicted 
that most patients were of borderline (58.27%). 
 
Table 1: Descriptive Characteristics of the Patients 
with Acute Myocardial Infarction (AMI). 
Characteristics of Patients N Percentage (%) 
Gender 
Male 367 60.07 
Female 244 39.93 
Age 
40-49 years 90 14.73 
50-59 years 173 28.31 
60-69 years 209 34.21 
70-79 years 139 22.75 
Educational Level 
Matriculation 323 52.86 
Intermediate 115 18.82 
Bachelors 92 15.06 
Masters 81 13.26 
Marital Status 
Single 74 12.11 
Married 524 85.76 
Divorced 13 2.13 
Family System 
Joint 471 77.09 
Nuclear 140 22.91 
Occupation 
Yes 435 71.19 
No 118 19.31 
House wife 85 9.49 
Anxiety Level 
Normal 8 1.31 
Borderline 287 46.97 
Abnormal 316 51.72 
Depression Level 
Normal 42 6.87 
Borderline 356 58.27 
Abnormal 213 34.86 
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Comparison between Male and 
Female Patients on the Levels of 
Anxiety and Depression 
Table 2 shows a significant difference in 
the level of anxiety (t (609) = 4.535, p < 
0.05) and depression (t (609) = 6.905, p 
< 0.05) among male and female patients 
with Acute Myocardial Infarction. Thus, 
this result helped us to conclude that 
anxiety and depression were more 
 




(n = 367) 
Female 






Mean (SD) Mean (SD) t (df) 
Anxiety 11.20(5.092) 13.46 (4.581) 4.535 (609) 0.001* 
Depression 10.40 (6.042) 11.01 (5.735) 6.905 (609) 0.000* 
 
*p < 0.05 
 
prevalent in female patients with AMI. 
 
DISCUSSION 
The current study findings presented an initial 
view of the incidence of anxiety and depression 
among Acute Myocardial Infarction patients 
during the COVID-19 pandemic in Pakistan. 
Depression and anxiety are known as one of the 
major risk factors for unfavorable medical 
conditions in patients with AMI. 
 The result of the present study reveals that 
anxiety (51.72%) and depression (34.86%) have a 
high frequency rate among AMI patients. During 
COVID-19 pandemic significant increase in 
anxiety19 and depression have been found; 
however, similar findings in the context of 
depression have been reported by Maqsood 
et al.20 In another study, cardiac problems are 
highly related to anxiety and depressive 
symptoms.21 
 In the current study, significant differences 
have been obtained in the level of anxiety and 
depression among male and female patients and, 
also elevated levels of anxiety and depression are 
found in females as compared to male patients. 
These results are supported by previous 
researches that female patients experience high 
levels of anxiety and depressive symptoms when 
compared to male patients.22 Whereas, in cardiac 
patients, anxiety and depressive symptoms are 
generally more common concerns for male and 
female. On the other hand, female heart patients 
often have more symptoms of depression and 
anxiety than male patients.23 
 Although significant findings are revealed in 
the current study, but this should be considered 
in the light of some limitations. However, a 
sample is not enough to generalize the findings; 
thus, data should be collected from a large 
number of patients to generalize it. The sample is 
only limited to the Cardiology ward of Dera Ghazi 
Khan Teaching Hospital; thus, future researches 
should consider collecting samples from other 
hospitals too. Additionally, long term follow-up 
for anxiety and depressive signs and symptoms in 
patients are not taken due to limited time, 
therefore, future studies should also work on it. 
 
CONCLUSION 
The present study findings affirmed that a high 
level of anxiety and depression are prevalent in 
AMI during COVID-19 pandemic. Additionally, 
both anxiety and depression symptoms were 
more common in female patients. Thus, in the 
AMI treatment plan, psychiatric/psychologist 
consultation should be included in the 
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